Long Acting Injectable | List of Frontiers open access articles

Original Research

Published on 19 Mar 2025

“Any time because I am ready”: Willingness to use long-acting injectable HIV PrEP among female barmaids in Dar es Salaam, Tanzania

in Public Health Education and Promotion

Winfrida Onesmo Akyoo
Idda Hubert Mosha
Albrecht Jahn
Rose Mpembeni

Frontiers in Public Health

doi 10.3389/fpubh.2025.1511801

1,748 views
1 citation

Review

Published on 01 Sep 2025

Optimizing long-acting injectable antipsychotic safety and care continuity through documentation best practices

in Psychopharmacology

Amie R. Throneberry
Bradley G. Burk
Brandon S. Pruett

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1659290

4,544 views
1 citation

Original Research

Published on 09 Jul 2025

Prediction of drug concentrations in humans for long-acting injectable suspensions by a semi-mechanical muscle compartment model: a case study of paliperidone palmitate

in Drug Metabolism and Transport

Panpan Yu
Mengjun Zhang
Xiong Jin
Keheng Wu
Sihui Long
Shishi Cheng
Long Fu
Xiao Xu
Jie Liu
Dan Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1507828

2,675 views

Original Research

Published on 26 Jan 2021

Comparative Study on Pharmacokinetics of Four Long-Acting Injectable Formulations of Enrofloxacin in Pigs

in Veterinary Pharmacology and Toxicology

Salah Uddin Ahmad
Jichao Sun
Fusheng Cheng
Bing Li
Safia Arbab
Xuzheng Zhou
Jiyu Zhang

Frontiers in Veterinary Science

doi 10.3389/fvets.2020.604628

10,213 views
8 citations

Correction

Published on 31 Oct 2025

Correction: Rating opportunity for long-acting injectable antipsychotic initiation index (ROLIN)

in Schizophrenia

Petru Ifteni
Paula-Simina Petric
Andreea Teodorescu

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1718142

765 views

Case Report

Published on 23 Mar 2021

Using Microdosing to Induct Patients Into a Long-Acting Injectable Buprenorphine Depot Medication in Low Threshold Community Settings: A Case Study

in Neuropharmacology

Joseph Tay Wee Teck
Alexander Baldacchino
Lauren Gibson
Con Lafferty

Frontiers in Pharmacology

doi 10.3389/fphar.2021.631784

19,907 views
12 citations

Original Research

Published on 19 May 2022

Second-Generation Long-Acting Injectable Antipsychotics and the Risk of Treatment Failure in a Population-Based Cohort

in Pharmacoepidemiology

Donica Janzen
James M. Bolton
Christine Leong
I fan Kuo
Silvia Alessi-Severini

Frontiers in Pharmacology

doi 10.3389/fphar.2022.879224

3,573 views
3 citations

Systematic Review

Published on 15 Dec 2021

Long-Acting Injectable Antipsychotic Treatment in Schizophrenia and Co-occurring Substance Use Disorders: A Systematic Review

in Schizophrenia

Alexandria S. Coles
Dunja Knezevic
Tony P. George
Christoph U. Correll
John M. Kane
David Castle

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.808002

20,883 views
34 citations

Original Research

Published on 07 Dec 2021

Rating Opportunity for Long-Acting Injectable Antipsychotic Initiation Index (ROLIN)

in Schizophrenia

Petru Ifteni
Paula-Simina Petric
Andreea Teodorescu

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.767756

3,251 views
7 citations

Systematic Review

Published on 08 Jan 2024

A systematic review of approaches to improve medication adherence in homeless adults with psychiatric disorders

in Psychopathology

Rachel Hird
Rajiv Radhakrishnan
Jack Tsai

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1339801

13,305 views
10 citations

Case Report

Published on 11 Feb 2026

Case Report: Atypical neuroleptic malignant syndrome induced by paliperidone palmitate—diagnostic challenges and clinical considerations

in Psychopharmacology

Omar El Oumary
Hicham Laaraj
Mina Ouhamou
Khalid Mouhadi
Jalal Doufik
Khadija Akebour
Saliha Hamri
Ismail Rammouz

Frontiers in Psychiatry

doi 10.3389/fpsyt.2026.1718815

525 views

Original Research

Published on 09 Dec 2025

Experiences and perceptions of patients, caregivers, and healthcare professionals with long-acting injectable antipsychotics for the treatment of schizophrenia: qualitative results from the multinational ADVANCE study

in Schizophrenia

Kelli R. Franzenburg
Rolf Hansen
Mark Suett
Ayelet Yaari
Martin Sergerie
Aviva Peyser Levin
Sigal Kaplan
Alma Gonzalez
Kameron Sedigh
Stephan Heres

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1645328

1,792 views
2 citations

Case Report

Published on 01 Dec 2022

The pathophysiology of rapid fluctuations in mental status associated with olanzapine: A case report

in Psychopharmacology

Tyler J. Torrico

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.1028350

4,597 views
3 citations

Original Research

Published on 30 Jul 2024

A Bayesian framework for virtual comparative trials and bioequivalence assessments

in Drugs Outcomes Research and Policies

Frederic Y. Bois
Céline Brochot

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1404619

2,857 views
5 citations

Perspective

Published on 14 Nov 2023

Efficient regulatory approval of two novel HIV prevention interventions in a resource-limited setting: experiences from Zimbabwe

in HIV and STIs

Caroline Murombedzi
Libert Chirinda
Gift T. Chareka
Z. Mike Chirenje
Nyaradzo M. Mgodi

Frontiers in Reproductive Health

doi 10.3389/frph.2023.1279124

3,779 views
7 citations

Original Research

Published on 23 Oct 2025

Anti-convulsant efficacy of long-acting injectable cannabidiol formulation (IVL5005) in the pentylenetetrazol-induced convulsions, with pharmacokinetic characterization

in Experimental Pharmacology and Drug Discovery

Soyoung Youm
Joo Young Cha
Slgirim Lee
Young Dai Seo
Kun Hee Park
Aeri Song
Hyun-Je Park
Woo Chan Son
Juhee Kim

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1692123

2,017 views

Articles

“Any time because I am ready”: Willingness to use long-acting injectable HIV PrEP among female barmaids in Dar es Salaam, Tanzania

Optimizing long-acting injectable antipsychotic safety and care continuity through documentation best practices

Prediction of drug concentrations in humans for long-acting injectable suspensions by a semi-mechanical muscle compartment model: a case study of paliperidone palmitate

Comparative Study on Pharmacokinetics of Four Long-Acting Injectable Formulations of Enrofloxacin in Pigs

Correction: Rating opportunity for long-acting injectable antipsychotic initiation index (ROLIN)

Using Microdosing to Induct Patients Into a Long-Acting Injectable Buprenorphine Depot Medication in Low Threshold Community Settings: A Case Study

Second-Generation Long-Acting Injectable Antipsychotics and the Risk of Treatment Failure in a Population-Based Cohort

Long-Acting Injectable Antipsychotic Treatment in Schizophrenia and Co-occurring Substance Use Disorders: A Systematic Review

Rating Opportunity for Long-Acting Injectable Antipsychotic Initiation Index (ROLIN)

A systematic review of approaches to improve medication adherence in homeless adults with psychiatric disorders

Case Report: Atypical neuroleptic malignant syndrome induced by paliperidone palmitate—diagnostic challenges and clinical considerations

Experiences and perceptions of patients, caregivers, and healthcare professionals with long-acting injectable antipsychotics for the treatment of schizophrenia: qualitative results from the multinational ADVANCE study

The pathophysiology of rapid fluctuations in mental status associated with olanzapine: A case report

A Bayesian framework for virtual comparative trials and bioequivalence assessments

Efficient regulatory approval of two novel HIV prevention interventions in a resource-limited setting: experiences from Zimbabwe

Anti-convulsant efficacy of long-acting injectable cannabidiol formulation (IVL5005) in the pentylenetetrazol-induced convulsions, with pharmacokinetic characterization